← April 24, 2026
society power

The EPA Wants to Test Your Water for Abortion Pills

The EPA Wants to Test Your Water for Abortion Pills
Center for Reproductive Rights

What happened

The Environmental Protection Agency quietly added 374 pharmaceutical drugs to its list of 'human health benchmarks,' which states use as guidelines to determine safe levels of pharmaceuticals in drinking water. Among the drugs listed are mifepristone and misoprostol, which together constitute the standard medication abortion regimen, as well as methotrexate (used both for abortions and cancer treatment) and several forms of oral contraceptives. The guidance is framed as a voluntary drinking water safety program, not a mandate. Senator Ron Wyden immediately demanded answers from the EPA, calling it 'uterus surveillance.' Oregon's governor issued a statement criticizing the proposal.

Calling this a water safety initiative requires believing that the EPA added abortion medication to a drinking water list at this political moment for reasons unconnected to abortion policy. That is not a serious position.

The Hidden Bet

1

Because the guidance is voluntary and framed around water safety, it has no practical effect on abortion access.

Voluntary guidance creates infrastructure. States that want to restrict medication abortion now have a federal environmental pretext to monitor mifepristone and misoprostol in water systems, which means monitoring sewage from households and clinics in close geographic proximity. The surveillance layer exists once the benchmarks exist, regardless of what the guidance says it is for.

2

The 374-drug list shows this is a broad pharmaceutical safety program, not specifically targeting abortion medication.

Adding 374 drugs is the cover, not the point. The political salience of the move comes entirely from the reproductive medications. If the list had excluded mifepristone and misoprostol, there would be no controversy and no news story. Their inclusion was a deliberate choice made in a deliberate context. The breadth of the list is rhetorical protection, not evidence of neutral intent.

3

Courts will block this as unconstitutional surveillance before it has practical effect.

This is guidance, not a rule. It does not require notice and comment under the Administrative Procedure Act in the same way a formal regulation does. Legal challenges will focus on whether it exceeds EPA statutory authority under the Safe Drinking Water Act, but that is a slower and less certain path than challenging a formal rule. The infrastructure can accumulate before litigation resolves.

The Real Disagreement

The real fork is about what the EPA's mandate actually encompasses. One reading: the Safe Drinking Water Act authorizes the EPA to monitor pharmaceuticals in water, reproductive medications appear in wastewater, and the agency has a legitimate environmental monitoring interest that happens to include these drugs. The other reading: the EPA's authority to monitor does not include building a secondary surveillance capability that enables state governments to infer medication abortion use patterns by geographic area, and that effect is the purpose, not a side effect. The first reading treats the guidance as technically legal and therefore acceptable. The second treats the foreseeable effects as the relevant test of intent. I take the second reading because the selective political timing makes the neutral-intent reading implausible. But I would acknowledge that 'foreseeable effect as intent' is a hard legal standard to meet.

What No One Is Saying

Wastewater epidemiology is a real and legitimate public health tool that was used extensively during COVID-19 to track infection rates by neighborhood. The EPA adding medication abortion drugs to a water monitoring list creates the same analytical capability for abortion: given enough data points, you can infer which households or clinics in a given water shed are using mifepristone and misoprostol. The administration does not need to mandate anything. It only needs to make the monitoring framework available to states that want to use it.

Who Pays

People using medication abortion in states with restrictive laws

Slow-burn; requires state implementation and political will, but the infrastructure is being created now

If the wastewater monitoring framework is adopted by hostile states and combined with geographic data, it creates a forensic trail that could be used to identify abortion providers or individuals in jurisdictions where medication abortion is criminalized or restricted.

Telehealth abortion providers

Medium-term if hostile states adopt the monitoring benchmarks

Mail-order mifepristone is the primary remaining access mechanism in states with abortion bans. A monitoring system that creates geographic signals about medication use could help hostile states identify patients receiving mifepristone by mail, complementing enforcement actions against providers.

EPA scientific staff

Immediate in terms of institutional credibility

Career EPA scientists who designed legitimate pharmaceutical water safety programs now have their work instrumentalized for a politically motivated surveillance function. This creates institutional damage that will outlast the current administration.

Scenarios

Infrastructure Without Mandate

The guidance remains voluntary. Three to five Republican-controlled states adopt it as part of drinking water monitoring programs. The actual surveillance use remains limited but present. No legislation passes, no court rules, and the framework normalizes over 18 months.

Signal One or more state environmental agencies formally incorporates the benchmarks into monitoring requirements within 90 days.

Legal Challenge Succeeds

Reproductive rights organizations file an APA challenge arguing the guidance exceeds EPA's Safe Drinking Water Act authority. A circuit court agrees and vacates the guidance. The administration withdraws and reframes the list without the reproductive medications.

Signal A coalition including the Center for Reproductive Rights and ACLU files a challenge within 30 days.

Congress Codifies

Republican-controlled Congress attaches a provision to an appropriations bill mandating that states adopt the EPA pharmaceutical benchmarks as a condition of certain federal water infrastructure funding. The voluntary guidance becomes effectively mandatory.

Signal A provision of this kind appears in a House appropriations markup within 60 days.

What Would Change This

If the EPA releases documentation showing that the reproductive medications were added based on environmental risk assessments prepared before the current administration, and not on political instruction, the intent argument weakens. That documentation would need to precede April 2025 to be credible.

Sources

KOIN (AP/local Oregon) — Reports Senator Wyden's 'uterus surveillance' framing and Oregon Governor Kotek's criticism. Focuses on political and reproductive rights dimensions.
HuffPost — Notes that the EPA added 374 pharmaceutical drugs total, including misoprostol, methotrexate, mifepristone, and oral contraceptives. Frames the scale as revealing the 'darker reality' underneath the ostensible water safety rationale.
Spot on Washington — Wyden's full letter demanding EPA answers. Characterizes the move as a 'backdoor attempt to strip access to reproductive health care' rather than a legitimate water safety initiative.

Related